How anti-neutrophil cytoplasmic autoantibodies activate neutrophils

被引:89
作者
Kettritz, R. [1 ,2 ,3 ]
机构
[1] Univ Med Berlin, Nephrol & Internist Intens Med Charite Virchow Kl, D-13125 Berlin, Germany
[2] Charite Med Fac, Expt Clin Res Ctr, Berlin, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
ANCA; neutrophils; pathogenesis; signal transduction; vasculitis; MEMBRANE PROTEINASE-3 EXPRESSION; ANCA-ASSOCIATED VASCULITIS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; TUMOR-NECROSIS-FACTOR; FC-GAMMA-RIIIB; SYSTEMIC VASCULITIS; CRESCENTIC GLOMERULONEPHRITIS; WEGENERS-GRANULOMATOSIS; PLASMA-MEMBRANE; MEDIATED GLOMERULONEPHRITIS;
D O I
10.1111/j.1365-2249.2012.04615.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OTHER ARTICLES PUBLISHED ON ANCA IN THIS ISSUE Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical and Experimental Immunology 2012, 169: 22937. Summary Neutrophils are pivotal to host defence during infectious diseases. However, activated neutrophils may also cause undesired tissue damage. Ample examples include small-vessel inflammatory diseases (vasculitis) that are associated with anti-neutrophil cytoplasmic autoantibodies (ANCA) residing in the patients' plasma. In addition to being an important diagnostic tool, convincing evidence shows that ANCA are pathogenic. ANCAneutrophil interactions induce important cellular responses that result in highly inflammatory necrotizing vascular damage. The interaction begins with ANCA binding to their target antigens on primed neutrophils, proceeds by recruiting transmembrane molecules to initiate intracellular signal transduction and culminates in activation of effector functions that ultimately mediate the tissue damage.
引用
收藏
页码:220 / 228
页数:9
相关论文
共 50 条
[1]   Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes [J].
Wiik, Allan .
MODERN RHEUMATOLOGY, 2009, 19 (06) :590-599
[2]   Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody [J].
Land, Judith ;
Rutgers, Abraham ;
Kallenberg, Cees G. M. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) :739-745
[3]   Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [J].
Gan, Poh-Yi ;
Ooi, Joshua D. ;
Kitching, A. Richard ;
Holdsworth, Stephen R. .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) :2380-2390
[4]   Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils [J].
Chen, Su-Fang ;
Wang, Feng-Mei ;
Li, Zhi-Ying ;
Yu, Feng ;
Chen, Min ;
Zhao, Ming-Hui .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis [J].
Savage, C. O. S. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 :23-26
[6]   Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis [J].
Sinico, Renato A. ;
Di Toma, Luca ;
Radice, Antonella .
AUTOIMMUNITY REVIEWS, 2013, 12 (04) :477-482
[7]   A historical essay on detection of anti-neutrophil cytoplasmic antibodies [J].
Rasmussen, Niels ;
Wiik, Allan ;
Jayne, David R. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 :i8-i13
[8]   Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis [J].
Coughlan, A. M. ;
Freeley, S. J. ;
Robson, M. G. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (03) :229-237
[9]   Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission [J].
Muto, Reiko ;
Inagaki, Koji ;
Sato, Naokazu ;
Sameshima, Tetsuro ;
Nagakura, Yuka ;
Baba, Satoshi ;
Kato, Noritoshi ;
Maruyama, Shoichi ;
Akahori, Toshiyuki .
INTERNAL MEDICINE, 2020, 59 (24) :3187-3193
[10]   Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis [J].
Zhao, MH ;
Lockwood, CM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (03) :397-402